Identification of gene signatures for invasive colorectal tumor cells

Cancer Detection and Prevention

Volumn 31, Issue 4, 2007, Pages 282-295

  Wiese, Anja H ^a,b   Auer, Johannes ^b   Lassmann, Silke ^c   Nährig, Jörg ^a   Rosenberg, Robert ^a   Höfler, Heinz ^a   Rüger, Rüdiger ^b   Werner, Martin ^c  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b ROCHE DIAGNOSTICS GMBH   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Colorectal carcinoma; Gene expression analysis; Gene signatures; Microarray; Microdissection

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CYCLIN DEPENDENT KINASE 2; GELATINASE A; GENE PRODUCT; MESSENGER RNA; MINICHROMOSOME MAINTENANCE PROTEIN; NONMETASTATIC CELL PROTEIN1; OSTEONECTIN; PROTEIN FBLN2; PROTEIN TKT; RNA; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG;

ARTICLE; CELL SPECIFICITY; CLUSTER ANALYSIS; COLORECTAL CARCINOMA; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; EPITHELIUM CELL; FROZEN SECTION; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MICRODISSECTION; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SAMPLING; STATISTICAL ANALYSIS; TUMOR CELL; UNINDEXED SEQUENCE; UPREGULATION; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENETIC MARKERS; HUMANS; MALE; MICRODISSECTION; MIDDLE AGED; NEOPLASM INVASIVENESS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, NEOPLASM; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 35248841521     PISSN: 0361090X     EISSN: 15251500     Source Type: Journal    
DOI: 10.1016/j.cdp.2007.07.003     Document Type: Article

References (67)

1. Nature genetics supplement. New York: Nature Pub; 1999.
2. Nature genetics supplement. New York: Nature Pub; 2002.
3. Golub T.R., Slonim D.K., Tamayo P., Huard C., Gaasenbeek M., Mesirov J.P., et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286 (1999) 531-537
4. Alon U., Barkai N., Notterman D.A., Gish K., Ybarra S., Mack D., et al. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc Natl Acad Sci USA 96 (1999) 6745-6750
5. Perou C.M., Jeffrey S.S., van de Rijn M., Rees C.A., Eisen M.B., Ross D.T., et al. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci USA 96 (1999) 9212-9217
6. van't Veer L.J., Dai H., van de Vijver M.J., He Y.D., Hart A.A., Mao M., et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415 (2002) 530-536
7. Ma X.J., Salunga R., Tuggle J.T., Gaudet J., Enright E., McQuary P., et al. Gene expression profiles of human breast cancer progression. Proc Natl Acad Sci USA 100 (2003) 5974-5979
8. Varambally S., Dhanasekaran S.M., Zhou M., Barrette T.R., Kumar-Sinha C., Sanda M.G., et al. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419 (2002) 624-629
9. Xin B., Platzer P., Fink S.P., Reese L., Nosrati A., Willson J.K., et al. Colon cancer secreted protein-2 (CCSP-2), a novel candidate serological marker of colon neoplasia. Oncogene 24 (2005) 724-731
10. Williams N.S., Gaynor R.B., Scoggin S., Verma U., Gokaslan T., Simmang C., et al. Identification and validation of genes involved in the pathogenesis of colorectal cancer using cDNA microarrays and RNA interference. Clin Cancer Res 9 (2003) 931-946
11. Shih W., Chetty R., and Tsao M.S. Expression profiling by microarrays in colorectal cancer (Review). Oncol Rep 13 (2005) 517-524
12. Sugiyama Y., Farrow B., Murillo C., Li J., Watanabe H., Sugiyama K., et al. Analysis of differential gene expression patterns in colon cancer and cancer stroma using microdissected tissues. Gastroenterology 128 (2005) 480-486
13. Liotta L., and Petricoin E. Molecular profiling of human cancer. Nat Rev Genet 1 (2000) 48-56
14. Liotta L.A., and Kohn E.C. The microenvironment of the tumour-host interface. Nature 411 (2001) 375-379
15. Schindler H., Wiese A., Auer J., and Burtscher H. cRNA target preparation for microarrays: comparison of gene expression profiles generated with different amplification procedures. Anal Biochem 344 (2005) 92-101
16. Sobin L.H., Wittekind C., and International Union against Cancer. TNM classification of malignant tumours. 6th ed. (2002), Wiley Liss Inc., New York
17. Aaltonen L.A., Hamilton S.R., World Health Organization, and International Agency for Research on Cancer. Pathology and genetics of tumors of the digestive system. World Health Organisation classification of tumours vol. 2 (2000), IARC Press, Lyon
18. van de Vijver M.J., He Y.D., van't Veer L.J., Dai H., Hart A.A., Voskuil D.W., et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347 (2002) 1999-2009
19. Wang Y., Jatkoe T., Zhang Y., Mutch M.G., Talantov D., Jiang J., et al. Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer. J Clin Oncol 22 (2004) 1564-1571
20. Arango D., Laiho P., Kokko A., Alhopuro P., Sammalkorpi H., Salovaara R., et al. Gene-expression profiling predicts recurrence in Dukes' C colorectal cancer. Gastroenterology 129 (2005) 874-884
21. Eisen M.B., Spellman P.T., Brown P.O., and Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95 (1998) 14863-14868
22. Tusher V.G., Tibshirani R., and Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98 (2001) 5116-5121
23. Van De Wiel M.A. Significance analysis of microarray using rank scores. Kwantitatieve Methoden (Neth Electron J Quat Methods 1) 71 (2004) 25-37
24. Luthra R., Wu T.T., Luthra M.G., Izzo J., Lopez-Alvarez E., Zhang L., et al. Gene expression profiling of localized esophageal carcinomas: association with pathologic response to preoperative chemoradiation. J Clin Oncol 24 (2006) 259-267
25. Hao Y., Triadafilopoulos G., Sahbaie P., Young H.S., Omary M.B., and Lowe A.W. Gene expression profiling reveals stromal genes expressed in common between Barrett's esophagus and adenocarcinoma. Gastroenterology 131 (2006) 925-933
26. Lassmann S., Hennig M., Rosenberg R., Nahrig J., Schreglmann J., Krause F., et al. Thymidine phosphorylase, dihydropyrimidine dehydrogenase and thymidylate synthase mRNA expression in primary colorectal tumors-correlation to tumor histopathology and clinical follow-up. Int J Colorectal Dis 21 3 Apr (2006) 238-247 Epub 2005 Aug 13
27. Notterman D.A., Alon U., Sierk A.J., and Levine A.J. Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. Cancer Res 61 (2001) 3124-3130
28. Koehler A., Bataille F., Schmid C., Ruemmele P., Waldeck A., Blaszyk H., et al. Gene expression profiling of colorectal cancer and metastases divides tumours according to their clinicopathological stage. J Pathol 204 (2004) 65-74
29. Kwon H.C., Kim S.H., Roh M.S., Kim J.S., Lee H.S., Choi H.J., et al. Gene expression profiling in lymph node-positive and lymph node-negative colorectal cancer. Dis Colon Rectum 47 (2004) 141-152
30. Bertucci F., Salas S., Eysteries S., Nasser V., Finetti P., Ginestier C., et al. Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters. Oncogene 23 (2004) 1377-1391
31. Srivastava S., Verma M., and Henson D.E. Biomarkers for early detection of colon cancer. Clin Cancer Res 7 (2001) 1118-1126
32. Toyooka S., Toyooka K.O., Harada K., Miyajima K., Makarla P., Sathyanarayana U.G., et al. Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomas. Cancer Res 62 (2002) 3382-3386
33. Zimovjanova M., Sykora V., Novotny J., Gatek J., Petruzelka L., Holubec L., et al. Comparative analysis of thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in colorectal cancer and surrounding normal tissue. Neoplasma 52 (2005) 208-210
34. Birkenkamp-Demtroder K., Christensen L.L., Olesen S.H., Frederiksen C.M., Laiho P., Aaltonen L.A., et al. Gene expression in colorectal cancer. Cancer Res 62 (2002) 4352-4363
35. Zou T.T., Selaru F.M., Xu Y., Shustova V., Yin J., Mori Y., et al. Application of cDNA microarrays to generate a molecular taxonomy capable of distinguishing between colon cancer and normal colon. Oncogene 21 (2002) 4855-4862
36. Tureci O., Ding J., Hilton H., Bian H., Ohkawa H., Braxenthaler M., et al. Computational dissection of tissue contamination for identification of colon cancer-specific expression profiles. Faseb J 17 (2003) 376-385
37. Friederichs J., Rosenberg R., Mages J., Janssen K.P., Maeckl C., Nekarda H., et al. Gene expression profiles of different clinical stages of colorectal carcinoma: toward a molecular genetic understanding of tumor progression. Int J Colorectal Dis 20 (2005) 391-402
38. Croner R.S., Foertsch T., Brueckl W.M., Guenther K., Siebenhaar R., Stremmel C., et al. Common denominator genes that distinguish colorectal carcinoma from normal mucosa. Int J Colorectal Dis 20 (2005) 353-362
39. Kitahara O., Furukawa Y., Tanaka T., Kihara C., Ono K., Yanagawa R., et al. Alterations of gene expression during colorectal carcinogenesis revealed by cDNA microarrays after laser-capture microdissection of tumor tissues and normal epithelia. Cancer Res 61 (2001) 3544-3549
40. Lin Y.M., Furukawa Y., Tsunoda T., Yue C.T., Yang K.C., and Nakamura Y. Molecular diagnosis of colorectal tumors by expression profiles of 50 genes expressed differentially in adenomas and carcinomas. Oncogene 21 (2002) 4120-4128
41. Gillespie J.W., Ahram M., Best C.J., Swalwell J.I., Krizman D.B., Petricoin E.F., et al. The role of tissue microdissection in cancer research. Cancer J 7 (2001) 32-39
42. Croner R.S., Guenther K., Foertsch T., Siebenhaar R., Brueckl W.M., Stremmel C., et al. Tissue preparation for gene expression profiling of colorectal carcinoma: three alternatives to laser microdissection with preamplification. J Lab Clin Med 143 (2004) 344-351
43. Urbanowicz-Kachnowicz I., Baghdassarian N., Nakache C., Gracia D., Mekki Y., Bryon P.A., et al. Ckshs expression is linked to cell proliferation in normal and malignant human lymphoid cells. Int J Cancer 82 (1999) 98-104
44. Kayed H., Kleeff J., Ding J., Hammer J., Giese T., Zentgraf H., et al. Expression analysis of MAC30 in human pancreatic cancer and tumors of the gastrointestinal tract. Histol Histopathol 19 (2004) 1021-1031
45. Li M., Lin Y.M., Hasegawa S., Shimokawa T., Murata K., Kameyama M., et al. Genes associated with liver metastasis of colon cancer, identified by genome-wide cDNA microarray. Int J Oncol 24 (2004) 305-312
46. Bevilacqua G., Sobel M.E., Liotta L.A., and Steeg P.S. Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. Cancer Res 49 (1989) 5185-5190
47. Postel E.H., Berberich S.J., Flint S.J., and Ferrone C.A. Human c-myc transcription factor PuF identified as nm23-H2 nucleoside diphosphate kinase, a candidate suppressor of tumor metastasis. Science 261 (1993) 478-480
48. Subramanian C., Cotter II M.A., and Robertson E.S. Epstein-Barr virus nuclear protein EBNA-3C interacts with the human metastatic suppressor Nm23-H1: a molecular link to cancer metastasis. Nat Med 7 (2001) 350-355
49. Kidd E.A., Yu J., Li X., Shannon W.D., Watson M.A., and McLeod H.L. Variance in the expression of 5-fluorouracil pathway genes in colorectal cancer. Clin Cancer Res 11 (2005) 2612-2619
50. Shayesteh L., Lu Y., Kuo W.L., Baldocchi R., Godfrey T., Collins C., et al. PIK3CA is implicated as an oncogene in ovarian cancer. Nat Genet 21 (1999) 99-102
51. Ma Y.Y., Wei S.J., Lin Y.C., Lung J.C., Chang T.C., Whang-Peng J., et al. PIK3CA as an oncogene in cervical cancer. Oncogene 19 (2000) 2739-2744
52. Woenckhaus J., Steger K., Werner E., Fenic I., Gamerdinger U., Dreyer T., et al. Genomic gain of PIK3CA and increased expression of p110alpha are associated with progression of dysplasia into invasive squamous cell carcinoma. J Pathol 198 (2002) 335-342
53. Vigneswaran N., Wu J., Muller S., Zacharias W., Narendran S., and Middleton L. Expression analysis of cystatin C and M in laser-capture microdissectioned human breast cancer cells-a preliminary study. Pathol Res Pract 200 (2005) 753-762
54. Fay M.J., Longo K.A., Karathanasis G.A., Shope D.M., Mandernach C.J., Leong J.R., et al. Analysis of CUL-5 expression in breast epithelial cells, breast cancer cell lines, normal tissues and tumor tissues. Mol Cancer 2 (2003) 40
55. Korkola J.E., DeVries S., Fridlyand J., Hwang E.S., Estep A.L., Chen Y.Y., et al. Differentiation of lobular versus ductal breast carcinomas by expression microarray analysis. Cancer Res 63 (2003) 7167-7175
56. Diederichs S., Bulk E., Steffen B., Ji P., Tickenbrock L., Lang K., et al. S100 family members and trypsinogens are predictors of distant metastasis and survival in early-stage non-small cell lung cancer. Cancer Res 64 (2004) 5564-5569
57. Lian Z., Liu J., Li L., Li X., Tufan N.L., Wu M.C., et al. Human S15a expression is upregulated by hepatitis B virus X protein. Mol Carcin 40 (2004) 34-46
58. Werb Z. ECM and cell surface proteolysis: regulating cellular ecology. Cell 91 (1997) 439-442
59. Timpl R., Sasaki T., Kostka G., and Chu M.L. Fibulins: a versatile family of extracellular matrix proteins. Nat Rev Mol Cell Biol 4 (2003) 479-489
60. Nemoto T., Kubota S., Ishida H., Murata N., and Hashimoto D. Ornithine decarboxylase, mitogen-activated protein kinase and matrix metalloproteinase-2 expressions in human colon tumors. World J Gastroenterol 11 (2005) 3065-3069
61. Orimo A., and Weinberg R.A. Stromal fibroblasts in cancer: a novel tumor-promoting cell type. Cell Cycle 5 (2006) 1597-1601
62. Brand S., Dambacher J., Beigel F., Olszak T., Diebold J., Otte J.M., et al. CXCR4 and CXCL12 are inversely expressed in colorectal cancer cells and modulate cancer cell migration, invasion and MMP-9 activation. Exp Cell Res 310 (2005) 117-130
63. Saad R.S., Liu Y.L., Nathan G., Celebrezze J., Medich D., and Silverman J.F. Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in colorectal cancer. Mod Pathol 17 (2004) 197-203
64. van Es J.H., and Clevers H. Notch and Wnt inhibitors as potential new drugs for intestinal neoplastic disease. Trends Mol Med 11 (2005) 496-502
65. Agrawal D., Chen T., Irby R., Quackenbush J., Chambers A.F., Szabo M., et al. Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling. J Natl Cancer Inst 94 (2002) 513-521
66. Agarwal A., Das K., Lerner N., Sathe S., Cicek M., Casey G., et al. The AKT/I kappa B kinase pathway promotes angiogenic/metastatic gene expression in colorectal cancer by activating nuclear factor-kappa B and beta-catenin. Oncogene 24 (2005) 1021-1031
67. El-Kabbani O., Darmanin C., and Chung R.P. Sorbitol dehydrogenase: structure, function and ligand design. Curr Med Chem 11 (2004) 465-476